I agree that this site is using cookies. You can find further informations here.
X
Glassman, Fiona Y.
235  results:
Search for persons X
?
1

Rational design of a nanoparticle platform for oral prophyl..:

Nguyen, Nhan H. ; Glassman, Fiona Y. ; Dingman, Robert K....
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
2

Subcutaneous administration of Lyso-phosphatidylserine nano..:

Glassman, Fiona Y. ; Balu-Iyer, Sathy V.
International Journal of Pharmaceutics.  548 (2018)  1 - p. 642-648 , 2018
Link: https://doi.org/10.1016/..
 
?
3

Phosphatidylserine Is Not Just a Cleanup Crew but Also a We..:

Glassman, Fiona Y. ; Schneider, Jennifer L. ; Ramakrishnan, Radha...
Journal of Pharmaceutical Sciences.  107 (2018)  8 - p. 2048-2054 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Rational design of a nanoparticle platform for oral prophyl..:

Nguyen, Nhan H ; Glassman, Fiona Y ; Dingman, Robert K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426360/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Biological Function and Immunotherapy Utilizing Phosphatidy..:

Glassman, Fiona Y ; Dingman, Robert ; Yau, Helena C.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508804/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
6

Subcutaneous Administration of Lyso-Phosphatidylserine Nano..:

Glassman, Fiona Y ; Balu-Iyer, Sathy V
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095657/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
7

Phosphatidylserine is not just a cleanup crew but also a we..:

Glassman, Fiona Y ; Schneider, Jennifer L ; Ramakrishnan, Radha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047910/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
8

Rational design of a nanoparticle platform for oral prophyl..:

Nhan H. Nguyen ; Fiona Y. Glassman ; Robert K. Dingman...
https://doi.org/10.1038/s41598-021-97333-0.  , 2021
Link: https://doi.org/10.1038/..
 
?
9

Population Pharmacokinetic/Pharmacodynamic Analysis Of Gara..:

Glassman, Fiona ; Sharma, Ankur ; Cheng, Shen...
Journal of Allergy and Clinical Immunology.  153 (2024)  2 - p. AB4 , 2024
Link: https://doi.org/10.1016/..
 
?
10

A Phase 1, Randomized, Open-label, Parallel-group Study Com..:

Glassman, Fiona ; Lawo, John-Philip ; Bica, Alex...
Journal of Allergy and Clinical Immunology.  153 (2024)  2 - p. AB7 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Efficacy and safety of garadacimab, a factor XIIa inhibitor..:

Craig, Timothy J ; Reshef, Avner ; Li, H Henry...
The Lancet.  401 (2023)  10382 - p. 1079-1090 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Efficacy, pharmacokinetics, and safety of subcutaneous C1-e..:

Fukuda, Tomoo ; Yamagami, Keiko ; Kawahata, Kimito...
Allergology International.  72 (2023)  3 - p. 451-457 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Phase 1 Study to Evaluate the Pharmacokinetics, Pharmacodyn..:

Glassman, Fiona ; Goodson, Summer ; Bica, Alex...
Journal of Allergy and Clinical Immunology.  151 (2023)  2 - p. AB144 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Systemic IgG Exposure and Safety in Patients with Primary I..:

Wasserman, Richard L ; Cunningham-Rundles, Charlotte ; Anderson, John...
Immunotherapy.  14 (2022)  16 - p. 1315-1328 , 2022
Link: https://doi.org/10.2217/..
 
?
15

Pharmacokinetic/pharmacodynamic modeling for dose selection..:

Pawaskar, Dipti ; Chen, Xi ; Glassman, Fiona...
Clinical and Translational Science.  15 (2021)  3 - p. 709-720 , 2021
Link: https://doi.org/10.1111/..
 
1-15